Authorizing a pharmacist to substitute an interchangeable biological product for the prescribed product under specified circumstances; requiring a pharmacist or the pharmacist's designee, except under specified circumstances, to inform specified consumers of the availability of an interchangeable biological product and the approximate cost difference as compared to a specified drug; requiring the State Board of Pharmacy to maintain on its Web site a link to a specified list of biological products; etc.
Bill File Type: Regular
Effective Date(s): October 1, 2017
( 12-101, 12-504, 12-504.1 )
Last Updated: 2/3/2020 2:35 PM